Dishman Carbogen Amcis updates on inspection by EDQM and AIFA
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
The products will be manufactured at the company's facility in Bengaluru
The product is expected to start contributing meaningfully to the revenue from FY25
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Subscribe To Our Newsletter & Stay Updated